These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11171003)

  • 21. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Escherichia coli strains causing urinary tract infections in patients with transposed intestinal segments.
    Keegan SJ; Graham C; Neal DE; Blum-Oehler G; N'Dow J; Pearson JP; Gally DL
    J Urol; 2003 Jun; 169(6):2382-7. PubMed ID: 12771802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infection.
    Alteri CJ; Himpsl SD; Mobley HL
    PLoS Pathog; 2015 Jan; 11(1):e1004601. PubMed ID: 25568946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virulence properties of asymptomatic bacteriuria Escherichia coli.
    Mabbett AN; Ulett GC; Watts RE; Tree JJ; Totsika M; Ong CL; Wood JM; Monaghan W; Looke DF; Nimmo GR; Svanborg C; Schembri MA
    Int J Med Microbiol; 2009 Jan; 299(1):53-63. PubMed ID: 18706859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of virulence factors of Escherichia coli from children by multiplex polymerase chain reaction.
    Arisoy M; Aysev D; Ekim M; Ozel D; Köse SK; Ozsoy ED; Akar N
    Int J Clin Pract; 2006 Feb; 60(2):170-3. PubMed ID: 16451289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.
    Anderson GG; Dodson KW; Hooton TM; Hultgren SJ
    Trends Microbiol; 2004 Sep; 12(9):424-30. PubMed ID: 15337164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a modular pathogenicity island that is widespread among urease-producing uropathogens and shares features with a diverse group of mobile elements.
    Flannery EL; Mody L; Mobley HL
    Infect Immun; 2009 Nov; 77(11):4887-94. PubMed ID: 19687197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of septic shock and multiple organ injury induced by urinary tract infection with Morganella morganii subsp. morganii].
    Tan JY; Zhang YK; Wu MZ; Yuan CL
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Sep; 25(9):565. PubMed ID: 24059431
    [No Abstract]   [Full Text] [Related]  

  • 29. [Virulence factor of Escherichia coli strains isolated during asymptomatic bacteriura among patients treated by drugs with acetylcholine antagonistic activity in a psychiatric institute].
    Bourlioux F; Eveillard M; Le Bouguenec C; Bourlioux P
    Ann Pharm Fr; 2001 Feb; 59(1):22-32. PubMed ID: 11223576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters.
    Jones GL; Muller CT; O'Reilly M; Stickler DJ
    J Antimicrob Chemother; 2006 Feb; 57(2):266-72. PubMed ID: 16339844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-like receptors recognize uropathogenic Escherichia coli and trigger inflammation in the urinary tract.
    Anders HJ; Patole PS
    Nephrol Dial Transplant; 2005 Aug; 20(8):1529-32. PubMed ID: 15941847
    [No Abstract]   [Full Text] [Related]  

  • 32. The etiology of urinary tract infection: traditional and emerging pathogens.
    Ronald A
    Dis Mon; 2003 Feb; 49(2):71-82. PubMed ID: 12601338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli).
    Bauer RJ; Zhang L; Foxman B; Siitonen A; Jantunen ME; Saxen H; Marrs CF
    J Infect Dis; 2002 May; 185(10):1521-4. PubMed ID: 11992291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
    Khan AU; Musharraf A
    Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ammonia encephalopathy secondary to urinary tract infection with Proteus mirabilis.
    Samtoy B; DeBeukelaer MM
    Pediatrics; 1980 Feb; 65(2):294-7. PubMed ID: 6444460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
    Ratliff TL
    J Urol; 2005 Sep; 174(3):1150. PubMed ID: 16094085
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlation between blood group phenotype and virulence properties of Escherichia coli in patients with chronic urinary tract infection.
    Ziegler T; Jacobsohn N; Fünfstück R
    Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S70-5. PubMed ID: 15364312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Study of Urease
    Ridha Abbas Al-Fahham H; Raoof Kareem K
    Arch Razi Inst; 2022 Jun; 77(3):1257-1260. PubMed ID: 36618312
    [No Abstract]   [Full Text] [Related]  

  • 40. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
    Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG
    Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.